Oncotarget Led Study On E-Cigarettes

E-cigarettes have been growing in popularity ever since their initial inception. There is a common belief that e-cigs are a healthier alternative to regular cigarettes. Though this may be true, they have been found to not actually be a health choice at all. A study led by Ifran Rahman has found that e-cigs are causing damage to gums and have the potential hazard of leading to gum disease. At the molecular level it has been found that the inflammatory proteins released during vaporization is irritating the gum cells and hurting them over time. Obviously the more one uses e-cigs the more cumulative damage will occur. To add to this, the flavoring chemicals are not doing the gums any favors as they are also causing damage to the cells. Nicotine is also involved in e-cigs which are also an ingredient in cigarettes. This is an addictive ingredient that also has the potential to lead to gum disease. Though the simply healthy solution to not letting e-cigs effect you is to stop smoking them, many people are simply ignorant to the fact that they are bad for you at all. Fortunately for us, a medical man by the name of Ifran Rahman who is a Professor of Medicine and holds a PHD, has a sneaking suspicion that there might be some problems involved in consuming them. The study about e-cigs was led by him. Check Oncotarget at scimagojr.com

Ifran Rahman hopes companies will choose to be transparent in noting all the products being utilized in the production of e-cigs. So far this has not been the case s ingredients not listed have been found to exist in the products. As more ingredients are uncovered, it will be easier for people like Ifran Rahman to deduce and test health effects.

Oncotarget is a peer reviewed journal that utilized the opinion and facts formed through the wisdom and experience of medical professionals all over. They simply seek to formulate better medical protocols and improve patient satisfaction and care. Thus far they have done a good job as they are well on their way to improving the medical industry.

Read more: http://www.bioxbio.com/if/html/ONCOTARGET.html

Leave a Reply

Your email address will not be published. Required fields are marked *